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ABSTRACT
Latent tuberculosis infection (LTBI) is a condition that has no clinical signs and symptoms. 
LTBI patients are characterized by persistent immune responses to Mycobacterium tuberculosis, 
and approximately 5-10% of these infected individuals will develop active TB at some point 
in their lives. The antigen transporter associated with antigen processing (TAP1) is a protein 
involved in the transport of the antigen from the cytoplasm to the endoplasmic reticulum by 
means of the association with MHC class I molecules. It plays a fundamental role in the immune 
response, promoting the clearance of intracellular pathogens. Our pilot study aimed to determine 
the association between TAP1 gene 1177A>G (rs1057141) and 2090A>G (rs1135216) genetic 
polymorphisms with susceptibility to LTBI. In this case-control study, 153 individuals from 
shelters were analyzed (46 were LTBI-positive and 92 were controls). Genotyping of the 
rs11352216 (2090A>G) and rs1057141 (1177A>G) gene IDs was performed using the Applied 
Biosystems Step One Thermal Cycler Real-Time PCR allelic discrimination technology. The 
haplotypic analyses were performed with the Arlequin 3.5 program. Social assistance centers 
and shelters that serve vulnerable populations represent high-risk sites due to overcrowding 
and the impaired nutritional status of their residents. The G allele (OR=1.99, CI=1.109-3.587, 
p=0.021) and the GG genotype of rs11352216 (A>G) were associated with susceptibility to 
LTBI, according to the codominant genetic model (OR=8.32, CI=1.722-61.98, p=0.007). The 
rs1057141 (A>G) polymorphism was not associated with LTBI risk. The results suggest that 
carriers of the G allele of rs1135216 (A>G) are susceptible to LTBI.
KEYWORDS: Latent tuberculosis infection. Genetic susceptibility. Mycobacterium 
tuberculosis. TAP1.
INTRODUCTION
Tuberculosis (TB) is a public health problem and a threat to human health 
worldwide, given that it is one of the global top ten causes of death. According to 
2019 World Health Organization (WHO) estimates, 10 million people fell ill with TB, 
approximately 1.5 million died, and about three million were undiagnosed1. In Mexico, 
there was an increase of 30,000 new cases of tuberculosis2. Therefore, tuberculosis 
in Mexico continues to be a public health challenge, requiring redoubled efforts.
Individuals that are in continuous contact with patients with active TB appear 
to have a higher risk of latent tuberculosis infection (LTBI). LTBI is due to 
Mycobacterium tuberculosis (Mtb) and is a medical condition in which patients do 
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not develop clinical signs or symptoms. It can also progress 
to active TB or persist for years in the host. In addition, these 
patients do not transmit the disease and are characterized 
by the presence of persistent immune responses to Mtb 
antigens3. About one-quarter of the world’s population 
is estimated to present with LTBI2 and 5 to 10% of these 
individuals will progress to active TB4.
Several factors increase the risk of developing active TB, 
such as the overcrowded living conditions present in shelters 
and prisons, malnutrition, drug use, prolonged therapy with 
corticosteroids, and the occupational exposure of health 
workers, mainly in countries with a high incidence of TB 
and in developing countries5.
Moreover, individuals with diabetes have a 3-fold 
increase in the risk of developing active TB and individuals 
with the human immunodeficiency virus (HIV) infection 
have 16 to 27-fold higher risk1,5.
Genetic association studies have reported that the presence 
of different polymorphisms in the VDR, IL12, IFNG, TAP1 
and TAP2 genes generates susceptibility to mycobacterial 
infections6-8. The TAP1 rs1057141 and rs1135216 single 
nucleotide polymorphisms (SNPs) have been associated with 
susceptibility to active TB, but no studies have explored the 
association of these SNPs with LTBI7,8.
TAP1/TAP2 are proteins that form the transporter 
associated with the antigen processing (TAP) and they 
are encoded by the TAP1 and TAP2 genes located on 
chromosome 6 in the major histocompatibility complex 
(MHC) region9. TAP proteins play a fundamental role 
in the immune response to promote the clearance of 
intracellular pathogens, such as Mtb. Mtb has developed 
different virulence factors that allow it to evade lysosomal 
degradation within infected macrophages, and thus avoiding 
the MHC-II antigen presentation pathway10. That action 
leads to the release of bacterial antigens into the cytosol, 
and then the process continue following the ubiquitin-
proteasome pathway11. The antigenic peptides generated 
are transported to the lumen of the endoplasmic-reticulum 
by TAP1/TAP2 proteins for cross-presentation12. Therefore, 
cross-presentation will be the last mechanism of the cellular 
response to eliminate the bacillus13.
The aim of the present pilot study was to investigate the 
possible association of the rs1057141 and rs1135216 genetic 
polymorphisms in the TAP1 gene with susceptibility to LTBI. 
MATERIALS AND METHODS
Subjects and sample collection
The 153 study participants were recruited from 
shelters offering social assistance in metropolitan areas 
of Guadalajara, Mexico, during 2019. Fifteen of the 
153 subjects were excluded because they did not fit the 
study criteria (comorbidities, such as HIV infection, 
diabetes mellitus, autoimmune diseases, and subjects with 
indeterminate QuantiFERON-TB Gold Plus - QFT-Plus 
results). Forty-six subjects were included and all of them 
were LTBI-positive. The control group was composed 
of 92 healthy subjects that had no known records of TB 
exposure, had a negative QFT-Plus test, and no clinical or 
radiological evidence of TB. Blood samples were drawn 
from LTBI cases and control subjects, in ethylene-diamine-
tetra-acetic acid (EDTA) and lithium-heparin tubes, for 
DNA extraction and evaluation by the QFT-Plus test.
Ethical issues 
The present study was reviewed and approved by the 
Ethical Investigation and Biosecurity Committee of the 
University Center of Health Sciences at the University 
of Guadalajara (approval CI-04218). The research was 
performed according to the Declaration of Helsinki and 
the Mexican regulations. Informed consent was signed by 
all the individuals.
LTBI evaluation
LTBI evaluation was performed through an interferon-
gamma release assay (IGRA), using QFT-Plus (QIAGEN, 
Hilden, Germany) to measure responses to ESAT-6 and 
CFP-10 peptide antigens. Blood containing lithium-heparin 
as anticoagulant was transferred to the QFT-Plus tubes 
(Nil-tube, TB1-tube, TB2-tube, and Mitogen-tube). A 
test was considered positive when, of the four tubes (Nil, 
TB1, TB2, Mitogen), either the TB1-tube or the TB2-tube 
presented with a value higher than the Nil IFN-γ IU/mLone. 
Subjects were considered LTBI-positive if they had a 
positive QFT-Plus test with no clinical or radiological 
evidence of active TB disease14.
DNA extraction
Genomic DNA was extracted from peripheral blood 
leukocytes of the cases and controls, using the High-Pure 
PCR Template Preparation Kit (Roche Molecular Systems, 
Indianapolis, USA), as described elsewhere.
Polymorphisms
The identification of SNPs was carried out through Real-
Time PCR using the allelic discrimination technology. The 
polymorphisms were identified by primers and TaqmanTM 
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hydrolysis probes for each of the SNPs specific to the 
wild-type and the polymorphic forms, using TAP1 gene ID 
rs1135216 (2090A>G), Cat_#531909_20; TAP1 rs1057141 
(1177A>G), Cat_#549926_20, (Applied BiosystemsTM, 
Foster City, USA), FastStart Essential DNA Probes Master 
(Roche Molecular Systems, Indianapolis, USA, catalog 
number 06402682001). The amplification reaction was 
performed in a StepOneTM Thermal-Cycler (Applied 
BiosystemsTM, Foster City, USA).
Statistical analysis
The genotypic and allelic frequencies of the 
polymorphisms were determined by direct counting. 
The Hardy-Weinberg equilibrium in the controls was 
determined using the chi-square test (c2). The distributions 
of the genotypes and allele frequencies in both groups 
(LTBI cases and controls) were analyzed using the c2 test. 
Non-parametric quantitative determinations, odds-ratio 
(OR) and 95% confidence interval (95% CI) were used 
to analyze the risk for LTBI associated with the TAP1 
gene polymorphism. To evaluate the effect of both 
polymorphisms on LTBI, we used genetic inheritance 
models and haplotypic analyses. The statistical analysis 
was performed using the Arlequin software, version 3.5 
(University of Bern, Germany), the SPSS Statistics for 
Windows, version 25.0 (IBM, Armonk, New York, USA) 
and the OpenEpi.com Statcalc (Andrew G. Dean and Kevin 
M. Sullivan, Atlanta, GA, USA). Statistical significance was 
set at a p<0.05, and the statistical power was 80%.
RESULTS
Population characteristics
The participants were divided into two groups: 46 LTBI 
cases, and 92 healthy controls. The groups were paired 
two-to-one, and the male: female ratio and mean age were 
similar between the groups. The demographic features of 
the cases and controls are summarized in Table 1.
Associat ion between LTBI and TAP1  gene 
polymorphisms
The genotypic and allelic frequencies of the 
TAP1  1177A>G and 2090A>G polymorphisms in the 
LTBI cases and controls are shown in Table 2. The genotype 
frequency distribution of both polymorphisms in the 
controls was in the Hardy-Weinberg equilibrium (p=0.157 
and 0.56, respectively). There were no statistical differences 
in the allele and genotype frequencies for the 1177A>G 
polymorphism between the LTBI cases and controls. 
Regarding the 2090A>G polymorphism, we observed a 
statistically significant difference in the distribution of 
genotype frequencies (p=0.013) between the study groups; 
individuals with LTBI presented a higher frequency of the 
GG polymorphic homozygote genotype than the controls 
(15.3% vs. 2.2%, respectively). In addition, the G allele 
of the rs1135216 (2090A>G) SNP was present in 30.4% 
of the cases, compared with 17.9% in the controls, with 
a statistically significant difference: OR=1.997, 95% 
CI=1.109-3.587, p=0.021 (Table 2).
When comparing the genotype frequencies of both 
groups (p=0.007, OR=8.328) for carriers of the GG 
genotype in the codominant model, we found a significant 
difference in the 2090A>G SNP, as well as significant 
differences in the recessive and additive models (Tables 2 
and 3).
In the inheritance model analysis by the Akaike 
Information Criteria for the 2090A>G SNP, we found a 
value of 11.08 for the GG codominant model (Table 2).
The haplotypic association analysis was performed in 
both study groups to analyze the combined effect of the 
two polymorphisms in the TAP1 gene and no statistically 
significant differences were observed between the four 
haplotypes.
DISCUSSION
The subjects studied had a prevalence of LTBI of 30%, 
consistent with reports from the WHO. The increased risk 
Table 1 - Demographic characteristics of LTBI cases and 
controls









Male 27 (58%) 52 (56%) 0.807
Female 19 (42%) 40 (44%)
Age (years)
Mean 21.4 22.6 0.631
Range 1-62 1 - 69
Age groups
Children 1-11* 13 19 1.0
Teenagers 12-20* 12 25 0.480
Adults 21-44* 16 39 0.272
Elderly > 45* 5 9 0.988
LTBI = latent tuberculosis infection; *Age in years. p values <0.05 
were considered statistically significant.
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n=92 OR 95% CI p
n % n %
1177A>G (rs1057141)
Genotype
AA 23 50 56 60.9 1.0
AG 16 34.8 30 32.6 1.296 0.587-2.833 0.516
GG 7 15.2 6 6.5 2.805 0.824-9.807 0.098
Allele
Aa 62 67.4 142 77.2 1.0
G 30 32.6 42 22.8 1.633 0.93 – 2.85 0.086
Total 92 100 184 100
2090A>G (rs1135216)
Genotype
AA 25 54.4 61 66.3 1.0
AG 14 30.4 29 31.5 1.176 0.524-2.597 0.685
GG 7 15.3 2 2.2 8.328 1.722-61.98 0.007
Allele
Aa 64 69.6 151 82.1 1.0
G 28 30.4 33 17.9 1.997 1.109-3.587 0.021
Total 92 100 184 100
Significant p values are shown in bold, and p-values < 0.05 were considered statistically significant; aReference category; OR = 
odds ratio; CI = confidence interval. The p-value was calculated by the Chi-squared test (c2). The Akaike information criteria in the 
codominant model to rs1135216 genotype GG: 11.088
Table 3 - Analysis of the inheritance models considering the SNPs (1177A>G, 2090A>G) in the TAP1 gene
SNPs Genotype
Cases Controls
OR 95% CI p Akaike 
n % n %
1177A>G (rs1057141)
Dominant
AAa 23 50 56 60.9 1.0
AG+GG 23 50 36 39.1 1.551 0.755-3.193 0.232
Recessive
AA+AGa 39 84.8 86 93.5 1.0
GG 7 15.2 6 6.5 2.553 0.778-8.591 0.121
Additive 0.647 0.382-1.095 0.105
2090A>G (rs1135216)
Dominant
AAa 25 54.4 61 66.3 1.0
AG+GG 21 45.7 31 33.7 1.647 0.793-3.421 0.180
Recessive
AA+AGa 39 84.8 90 97.8 1.0
GG 7 15.2 2 2.2 7.945 1.684-57.97 0.007 11.514
Additive 0.526 0.297-0.930 0.027 18.436
SNPs = single nucleotide polymorphisms; aReference category; OR = odds ratio, 95% CI confidence interval. Significant p values 
are shown in bold, and p-values <0.05 were considered statistically significant. The p-value was calculated by the Chi-squared test 
(c2). The Akaike information criteria were calculated for the polymorphisms presenting with more than one inheritance model and 
that had statistical significance.
of LTBI in our study population could be attributed to 
overcrowding, reported as a risk factor for TB15.
Other risk factors have been associated with the 
development of TB, such as host genetic factors. Studies 
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have shown that genetic polymorphisms play a crucial 
role in the establishment and progression of active 
TB16. Polymorphisms in the TAP gene may lead to low 
translocation of peptides, altering the MHC-I pathway17.
The allele frequencies obtained in the present study 
(Table 2) coincide with those reported in the 1000-Genome 
project, rs1057141(G=18.8%), rs1135216 (G=19.5%).
The rs1135216 polymorphism (2090A>G) was associated 
with susceptibility to LTBI (OR=1.997, 95% CI=1.109-
3.587, p=0.021), coinciding with results from other studies. 
A study on the Li population in China showed an association 
between the rs1135216 polymorphism (OR=2.87, 95% 
CI=1.75-4.71, p=<0.0001) in the TAP1 gene, in patients 
with active TB versus control subjects6, and a study on an 
Iranian population found an association with the rs1135216 
polymorphism for an increased TB risk (OR=2.65, 95% 
CI=1.78-396, p=<0.0001), but not with rs10571418. In 
contrast, a Korean population study found no association with 
TB for those bearing TAP1 gene polymorphisms7.
Furthermore, some polymorphisms have been associated 
with susceptibility to infections by other pathogens. Our 
group has recently found an association between a TAP1 gene 
polymorphism with recurrent respiratory papillomatosis18. 
Other studies on polymorphisms in the TAP gene have 
reported an increased susceptibility to hepatitis B virus 
(HBV), HIV and human papillomavirus (HPV) infections19,20.
In the codominant inheritance model of the 2090A>G 
polymorphism (rs1135216), the G allele (OR=8.328, 95% 
CI=1.722-61.98, p=0.007) was associated with an 8.3-fold 
increased risk. These results are consistent with the ones 
reported by Naderi et al.8, who found that the polymorphic 
homozygote genotype GG (OR=19.13, 95% CI=2.47-148.2, 
p=<0.001) was associated with an increased risk of TB, 
compared with AA.
When the haplotype frequencies of TAP1 were 
compared, no statistically significant differences were 
found, thus these haplotypes were not related to protection, 
i.e, a reduced susceptibility to LTBI in our study population. 
According to the haplotype analysis, the results resemble 
those of the report by Balladares et al.21 in a Mexican 
mestizo and Seri Sonora Indian population.
TAP1 gene association studies have focused on active 
TB due to its relevance, but we believe that it is also essential 
to study the population with LTBI. At any rate, the role 
of both conditions and their associations with TAP1 gene 
polymorphisms are unknown in the Mexican population. 
CONCLUSION
In summary, the results suggested that the rs1125216 
A>G polymorphism in TAP1 is associated with the risk 
of LTBI. The present study is the first to analyze genetic 
variants in subjects with LTBI, and it is also the first study 
of this in a Mexican population. Nevertheless, this was a 
pilot study, and future studies are needed to explain the 
association of these TAP1 gene polymorphisms with LTBI 
and their possible implication in the establishment and 
progression of to TB.
REFERENCES
 1. World Health Organization. Tuberculosis and HIV. [cited 2021 
Jun 5]. Available from: https://www.who.int/hiv/topics/tb/
about_tb/en/
 2.  México. Secretaría de Salud. Dirección General de Epidemiología. 
Boletín epidemiológico: Sistema Nacional de Vigilancia 
Epidemiológica, Sistema Único de Información: semana 53, 
del 27 de diciembre del 2020 al 2 de enero del 2021. [cited 
2021 Jun 5]. Available from: https://www.gob.mx/cms/uploads/
attachment/file/614743/sem53.pdf
 3. Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme 
CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.
 4.  O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, 
Berry MP. The immune response in tuberculosis. Annu Rev 
Immunol. 2013;31:475-527.
 5. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378:57-72.
 6.  Wang D, Zhou Y, Ji L, He T, Lin F, Lin R, et al. Association of 
LMP/TAP gene polymorphisms with tuberculosis susceptibility 
in Li population in China. PLoS One. 2012;7: e33051.
 7.  Roh EY, Yoon JH, Shin S, Song EY, Park MH. Association 
of TAP1 and TAP2 genes with susceptibility to pulmonary 
tuberculosis in Koreans. APMIS. 2015;123:457-64.
 8.  Naderi M, Hashemi M, Amininia S. Association of TAP1 and 
TAP2 gene polymorphisms with susceptibility to pulmonary 
tuberculosis. Iran J Allergy Asthma Immunol. 2016;15:62-8.
 9.  Monaco JJ. Structure and function of genes in the MHC class II 
region. Curr Opin Immunol. 1993;5:17-20.
 10.  Forrellad MA, Klepp LI, Gioffré A, Sabio y García J, Morbidoni 
HR, de la Paz Santangelo M, et al. Virulence factors of the 
Mycobacterium tuberculosis complex. Virulence. 2013;4:3-66.
 11.  Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, 
Johnson M, et al. Secreted proteins from Mycobacterium 
tuberculosis gain access to the cytosolic MHC-class-I antigen-
processing pathway. J Immunol. 2006;177:437-42.
 12.  Brookes RH, Pathan AA, McShane H, Hensmann M, Price DA, 
Hill AV. CD8+ T cell-mediated suppression of intracellular 
Mycobacterium tuberculosis growth in activated human 
macrophages. Eur J Immunol. 2003;33:3293-302.
 13.  Vigneron N, Van den Eynde BJ. Proteasome subtypes and 
regulators in the processing of antigenic peptides presented 
by class I molecules of the major histocompatibility complex. 
Biomolecules. 2014;4:994-1025.
Cazarez-Navarro et al.
Rev Inst Med Trop São Paulo. 2021;63:e55Page 6 of 6
 14.  Pourakbari B, Mamishi S, Benvari S, Mahmoudi S. Comparison 
of the QuantiFERON-TB Gold Plus and QuantiFERON-TB 
Gold In-Tube interferon-γ release assays: a systematic review 
and meta-analysis. Adv Med Sci. 2019;64:437-43.
 15.  Baker M, Das D, Venugopal K, Howden-Chapman P. Tuberculosis 
associated with household crowding in a developed country. J 
Epidemiol Community Health. 2008;62:715-21.
 16.  Ghanavi J, Farnia P, Farnia P, Velayati AA. Human genetic 
background in susceptibility to tuberculosis. Int J Mycobacteriol. 
2020;9:239-47.
 17.  Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S. TAP1 
mutant mice are deficient in antigen presentation, surface 
class-I molecules, and CD4-8 + T cells. Cell. 1992;71:1205-14.
 18.  Palomares-Marin J, Govea-Camacho LH, Araujo-Caballero 
V, Cazarez-Navarro G, Rodriguez-Preciado SY, Ortiz-
Hernandez E, et al. Association between the TAP1 gene 
polymorphisms and recurrent respiratory papillomatosis in 
patients from Western Mexico: a pilot study. J Clin Lab Anal. 
2021;35:e23712.
 19.  Qiu B, Huang B, Wang X, Liang J, Feng J, Chang Y, et al. 
Association of TAP1 and TAP2 polymorphisms with the 
outcome of persistent HBV infection in a northeast Han 
Chinese population. Scand J Gastroenterol. 2012;47:1368-74.
 20.  Abitew AM, Sobti RC, Sharma VL, Wanchu A. Analysis of 
transporter associated with antigen presentation (TAP) genes 
polymorphisms with HIV-1 infection. Mol Cell Biochem. 
2020;464:65-71.
 21.  Balladares S, Alaez C, Pujol J, Duran C, Navarro JL, Gorodezky 
C. Distribution of TAP gene polymorphisms and extended 
MHC haplotypes in Mexican Mestizos and in Seri Indians 
from northwest Mexico. Genes Immun. 2002;3:78-85.
